| US Stock Movers On FDA Decision (NBS, PRGO, KERX, OPXA, ACHN) - TransWorldNews (press release) |
|
|
TransWorldNews (press release)... of hyperphosphatemia (elevated phosphate levels) from an open-label extension study in patients with end-stage renal disease (ESRD) who are on dialysis. ... read more |